621
Participants
Start Date
October 31, 2011
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
TAK-438
TAK-438 10 mg tablets, orally, once daily for up to 24 weeks.
Placebo
Lansoprazole placebo-matching capsules, orally, once daily for up to 24 weeks.
TAK-438
TAK-438 20 mg tablets, orally, once daily for up to 24 weeks.
Placebo
Lansoprazole placebo-matching capsules, orally, once daily for up to 24 weeks.
Lansoprazole
Lansoprazole 15 mg capsules, orally, once daily for up to 24 weeks.
Placebo
TAK-438 placebo-matching tablets, orally, once daily for up to 24 weeks.
Komaki-shi
Seto-shi
Akita
Ichikawa-shi
Kisarazu-shi
Matsudo-shi
Imabari
Matsuyama
Niihama-shi
Fukui-shi
Chikushino-shi
Fukuoka
Kasuya-gun
Kitakyushu-shi
Miyako-gun
Onga-gun
Yanagawa-shi
Yukuhashi-shi
Koriyama-shi
Gifu
Takasaki-shi
Fukuyama-shi
Hatsukaichi-shi
Hiroshima
Asahikawa-shi
Obihiro-shi
Sapporo
Tomakomaki-shi
Kobe
Nishinomiya-shi
Takarazuka-shi
Koga-shi
Tsuchiura-shi
Kanazawa
Komatsu-shi
Nomi-shi
Shiroyama-shi
Takamatsu
Ibusuki-shi
Ichikikushikino-shi
Izumi-shi
Atsugi-shi
Kawasaki-shi
Sagamihara-shi
Yokohama
Kochi
Kumamoto
Kyoto
Uji-shi
Tsu
Sendai
Nagasaki
Nara
Niigata
Ōita
Osaka
Sakai-shi
Tondabayashi-shi
Ageo-shi
Hiki-gun
Kumagaya-shi
Saitama-shi
Sayama-shi
Tokorozawa-shi
Ōtsu
Utsunomiya
Adachi-ku
Hachioji-shi
Koto-ku
Meguro-ku
Minato-ku
Shinjuku-ku
Tonami-shi
Toyama
Iwakuni-shi
Shimonoseki-shi
Lead Sponsor
Takeda
INDUSTRY